Re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051–60

IF 8.3 1区医学 Q1 ONCOLOGY

European urology oncology Pub Date : 2025-02-07 DOI:10.1016/j.euo.2025.01.012

Francesco Montorsi , Giorgio Gandaglia , Francesco Barletta , Alberto Briganti

引用次数: 0

回复：Bertrand F. Tombal, Francisco Gomez-Veiga， Alvaro Gomez-Ferrer等。口服达罗卢胺单药治疗与雄激素剥夺治疗在男性激素敏感前列腺癌中的2期随机开放标签研究（EORTC-GUCG 1532）欧洲石油学报，2024;7:1051-60。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology oncology Multiple-

CiteScore

15.50

自引率

2.40%

发文量

128

审稿时长

20 days

期刊介绍： Journal Name: European Urology Oncology Affiliation: Official Journal of the European Association of Urology Focus: First official publication of the EAU fully devoted to the study of genitourinary malignancies Aims to deliver high-quality research Content: Includes original articles, opinion piece editorials, and invited reviews Covers clinical, basic, and translational research Publication Frequency: Six times a year in electronic format